Upgrade to SI Premium - Free Trial

Biora Therapeutics (BIOR) Misses Q3 EPS by 504c

November 14, 2024 5:13 PM

Biora Therapeutics (NASDAQ: BIOR) reported Q3 EPS of ($5.04). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Biora Therapeutics (BIOR) click here.

Categories

Earnings